Not enough was known about the risks attached to the active ingredient in the swine flu vaccine linked to narcolepsy in young people before it was offered to patients, according to Professor Timo Vesikari of Tampere University’s Vaccine Research Centre.
Vesikari said that the active agents had been tested in the vaccination for H5N1, or bird flu, not H1N1, which is known as swine flu.
In response, Terhi Kilpi of the National Institute for Health and Welfare said that no clinical trials could have uncovered the link to narcolepsy.
Leave a Reply